PRP vs Stem Cell Therapy: Which Is Right for You?
- At a Glance
- What Is PRP Therapy?
- What the Evidence Says About PRP
- What Is Stem Cell Therapy?
- What the Evidence Says About Stem Cell Therapy
- Head-to-Head Comparison: PRP vs Stem Cell Therapy
- Decision Framework: Which Treatment Is Right for Your Condition?
- When Combining PRP and Stem Cells Makes Sense
- Cost Considerations and Practical Realities
- Safety and Risks
- Frequently Asked Questions
- Is PRP or stem cell therapy better for knee arthritis?
- How long do the results of PRP and stem cell therapy last?
- Can I get PRP and stem cell therapy at the same time?
- Does insurance cover PRP or stem cell therapy?
- Related Reading
At a Glance
- PRP (Platelet-Rich Plasma) uses concentrated platelets from your own blood to stimulate healing – it is a same-day, minimally invasive procedure costing $500 to $2,000 per injection.
- Stem cell therapy uses mesenchymal stem cells (from bone marrow or fat tissue) to promote tissue repair – the procedure is more involved and costs $5,000 to $15,000 or more.
- PRP has a stronger evidence base for tendon injuries and mild-to-moderate osteoarthritis; stem cell therapy shows the most promise for moderate-to-severe joint degeneration.
- Many patients benefit from combining both therapies, and the best choice depends on your specific condition, severity, and budget.
- Neither treatment is a guaranteed cure – realistic expectations and proper patient selection are the keys to good outcomes.
If you have been exploring regenerative medicine for joint pain, a sports injury, or osteoarthritis, you have almost certainly encountered two treatments that dominate the conversation: PRP (platelet-rich plasma) and stem cell therapy. Both promise to use your body’s own biology to heal damaged tissue – but they work differently, cost differently, and carry different levels of scientific evidence.
The internet is full of clinics promoting one over the other, and separating genuine science from marketing can feel impossible. This guide provides a straightforward, evidence-based comparison so you can make an informed decision with your doctor – not based on a sales pitch.
What Is PRP Therapy?
Platelet-rich plasma therapy is one of the simplest regenerative treatments available. Here is how it works:
- Blood draw: A small sample of your blood (typically 30 to 60 mL) is drawn from your arm – no different from a routine lab test.
- Centrifuge processing: The blood is spun in a centrifuge for 10 to 15 minutes, separating the platelets and growth factors from red blood cells and other components.
- Injection: The concentrated platelet solution – now containing 3 to 10 times the normal platelet concentration – is injected directly into the damaged tissue, usually guided by ultrasound imaging.
The entire process takes about 45 minutes to an hour and is performed in an office setting. You walk out the same day.
Platelets are packed with growth factors like PDGF, TGF-beta, and VEGF that signal your body to ramp up its natural repair processes. Think of PRP as sending a concentrated repair crew to a specific injury site.
What the Evidence Says About PRP
PRP has a relatively strong evidence base, particularly for certain conditions:
- Tendinopathy (tennis elbow, Achilles tendinitis, patellar tendinitis): This is where PRP shines the brightest. Multiple randomized controlled trials (RCTs) show significant improvement compared to corticosteroid injections, with longer-lasting results.
- Mild-to-moderate knee osteoarthritis: Several meta-analyses support PRP over hyaluronic acid injections for pain relief and functional improvement, with benefits lasting 6 to 12 months.
- Muscle injuries: Emerging evidence suggests PRP may accelerate healing of acute muscle strains, though data is more limited.
Where PRP falls short: it is less effective for severe osteoarthritis (bone-on-bone) and large structural defects like complete tendon tears.
What Is Stem Cell Therapy?
Stem cell therapy for musculoskeletal conditions typically uses mesenchymal stem cells (MSCs) – cells with the ability to differentiate into cartilage, bone, and other connective tissue types. The most common sources are:
- Bone marrow aspirate concentrate (BMAC): Harvested from the iliac crest (hip bone) using a needle under local anesthesia. This is the most well-studied autologous source.
- Adipose-derived (SVF – stromal vascular fraction): Obtained via a small liposuction procedure, usually from the abdomen. Yields a higher cell count but involves a more invasive harvesting step.
- Umbilical cord / birth tissue products: Marketed as “stem cell” therapies, though most of these products contain growth factors and extracellular matrix rather than viable, living stem cells. The FDA has raised concerns about misleading marketing in this category.
The harvesting and processing procedure takes longer than PRP – typically 1.5 to 3 hours – and is more invasive, especially with bone marrow aspiration.
What the Evidence Says About Stem Cell Therapy
Stem cell therapy has a growing but less mature evidence base compared to PRP:
- Knee osteoarthritis: Several RCTs show improvement in pain scores and function, particularly for moderate OA (Kellgren-Lawrence grades 2-3). Some studies show cartilage preservation on MRI follow-up.
- Hip osteoarthritis: Limited but encouraging data, with some patients delaying or avoiding hip replacement.
- Disc degeneration: Early-phase trials show promise but are not yet conclusive.
Honest limitations: there are fewer large-scale RCTs for stem cells compared to PRP, the regulatory field is more complex, and outcomes are more variable depending on the cell source, processing method, and provider expertise.
Important: Know What You Are Getting
Not all “stem cell” treatments contain living stem cells. Many clinics offering umbilical cord or amniotic fluid products are selling growth factor preparations, not true stem cell therapy. Always ask your provider: What is the cell source? Is it autologous (your own cells)? Has cell viability been tested? These questions matter enormously for outcomes.
Head-to-Head Comparison: PRP vs Stem Cell Therapy
Here is how the two therapies stack up across the factors that matter most:
| Factor | PRP | Stem Cell Therapy |
|---|---|---|
| Source | Your own blood (platelets) | Bone marrow, fat tissue, or donor tissue |
| Procedure time | 30-60 minutes | 1.5-3 hours |
| Invasiveness | Simple blood draw | Bone marrow aspiration or liposuction |
| Cost per treatment | $500-$2,000 | $5,000-$15,000+ |
| Number of RCTs | Extensive (100+ for various conditions) | Growing (30+ for musculoskeletal) |
| Best evidence for | Tendinopathy, mild-moderate OA | Moderate-severe OA |
| Recovery time | 1-2 days of soreness | 3-7 days; avoid impact 4-6 weeks |
| Duration of benefit | 6-12 months (may need repeat) | 1-5 years |
| FDA status | Generally accepted (autologous, minimally manipulated) | Regulatory gray area; autologous BMAC is generally accepted, other products may not be |
| Insurance coverage | Rarely covered | Almost never covered |
Decision Framework: Which Treatment Is Right for Your Condition?
Rather than thinking of this as PRP versus stem cells, think of them as tools in a spectrum. The right choice depends on what you are treating and how far it has progressed.
| Condition / Severity | Recommended Approach | Why |
|---|---|---|
| Tendinopathy (tennis elbow, Achilles, patellar) | PRP first | Strongest evidence, lower cost, less invasive |
| Mild OA (KL grade 1-2) | PRP first | Good evidence at lower cost; save stem cells as a second line |
| Moderate OA (KL grade 2-3) | PRP or stem cells | Either may work; stem cells may be worth the investment for longer-lasting results |
| Severe OA (KL grade 3-4) | Stem cells (or surgical options) | PRP alone unlikely to provide adequate relief; stem cells may delay replacement |
| Bone-on-bone (KL grade 4) | Consider joint replacement | Neither PRP nor stem cells can rebuild absent cartilage; biologics have limited benefit here |
| Acute muscle or ligament injury | PRP | Faster, less invasive, appropriate for acute healing support |
When Combining PRP and Stem Cells Makes Sense
Many experienced regenerative medicine providers use PRP and stem cells together. The rationale is sound: PRP provides a concentrated cocktail of growth factors that can enhance the survival and activity of injected stem cells. Some protocols involve:
- Same-session combination: Stem cells (BMAC) injected alongside PRP into the joint.
- Staged approach: Stem cell injection followed by PRP “booster” injections at 4 to 8 week intervals to sustain the healing response.
- PRP first, stem cells later: Trying PRP as a first-line treatment; if the response is insufficient, escalating to stem cells.
This combined approach adds cost but may improve outcomes, particularly for moderate osteoarthritis. Discuss staging options with your provider.
Cost Considerations and Practical Realities
Because neither PRP nor stem cell therapy is typically covered by insurance, cost is a real factor in the decision:
- PRP: $500 to $2,000 per injection. Most patients need 1 to 3 injections, sometimes repeated annually. Total first-year cost: roughly $1,000 to $6,000.
- Stem cells: $5,000 to $15,000+ per treatment area. Usually a single treatment with possible PRP boosters. Total first-year cost: roughly $5,000 to $18,000.
A pragmatic approach: start with PRP if your condition is appropriate (mild-moderate severity, tendinopathy). If you get a partial response or the condition is more advanced, consider stem cell therapy as the next step. This way, you are not spending $10,000+ before knowing whether a $1,500 PRP injection might have done the job.
Red Flags When Choosing a Provider
Be cautious of any clinic that guarantees results, pressures you into expensive treatment packages upfront, claims stem cells can “regrow” cartilage, or uses vague language about their cell sources. A reputable provider will discuss evidence honestly, explain which source of cells they use and why, and will not oversell outcomes.
Safety and Risks
Both PRP and stem cell therapy have strong safety profiles when performed by qualified providers using autologous (your own) cells:
- PRP risks: Minimal – injection site soreness, minor swelling, very small risk of infection. Since it is your own blood, allergic reactions are essentially nonexistent.
- Stem cell risks: Slightly higher due to the harvesting procedure – bone marrow aspiration can cause hip soreness for several days, and liposuction carries minor surgical risks. Joint infection risk is very low but marginally higher than PRP due to longer procedure time.
The bigger risk with stem cells is not physical harm – it is financial harm from unproven products. Products marketed as “stem cell” injections that use non-autologous, non-FDA-compliant materials carry unknown risks and may deliver zero viable stem cells.
Frequently Asked Questions
Is PRP or stem cell therapy better for knee arthritis?
It depends on the severity. For mild-to-moderate knee osteoarthritis (Kellgren-Lawrence grade 1-3), PRP is a reasonable and less expensive first-line option with solid clinical evidence. For more advanced OA (grade 3-4), stem cell therapy – particularly BMAC – may offer more meaningful and longer-lasting improvement. For true bone-on-bone arthritis (grade 4), neither treatment is likely to eliminate the need for joint replacement, though stem cells may help delay surgery.
How long do the results of PRP and stem cell therapy last?
PRP benefits typically last 6 to 12 months, and many patients repeat treatments annually to maintain results. Stem cell therapy results tend to last longer – generally 1 to 5 years – though this varies based on the condition treated, the severity at the time of treatment, and patient factors like age, weight, and activity level. Neither treatment is permanent; both are slowing or temporarily reversing degeneration, not curing the underlying condition.
Can I get PRP and stem cell therapy at the same time?
Yes, and many providers recommend it. PRP can be administered alongside stem cells to enhance the local healing environment. The growth factors in PRP may support stem cell survival and activity at the injection site. Combined protocols add cost but may improve outcomes, particularly for moderate osteoarthritis.
Does insurance cover PRP or stem cell therapy?
In most cases, no. PRP is occasionally covered for specific indications by certain insurers, but it is the exception. Stem cell therapy is almost never covered by insurance. Both are considered out-of-pocket expenses. Ask your provider about payment plans – many regenerative medicine clinics offer financing options.
Related Reading
This article is part of our complete guide to regenerative medicine. For a deeper dive into stem cell therapy – including how it works, what conditions it treats, and how to find a qualified provider – visit our pillar guide: Stem Cell Therapy: The Complete Patient Guide.


